The insulin-like growth factor (IGF) signaling system is comprised of the IGF ligands (IGF-1 and IGF-2), the cell surface receptors that mediate the biological effects of the IGFs (IGF-1 receptor (IGF-1R), IGF-2 receptor and the insulin receptor), as well as a family of circulating IGF-binding proteins. Insulin-like growth factors 1 and 2 have a critical physiological role in the growth and development of many tissues, and are also implicated in various pathological conditions, particularly in multiple myeloma (MM).

Phase I study of the anti insulin-like growth factor1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and incombination with bortezomib in patients with relapsed multiple myeloma.

CAVALLO, Federica;BOCCADORO, Mario;
2011-01-01

Abstract

The insulin-like growth factor (IGF) signaling system is comprised of the IGF ligands (IGF-1 and IGF-2), the cell surface receptors that mediate the biological effects of the IGFs (IGF-1 receptor (IGF-1R), IGF-2 receptor and the insulin receptor), as well as a family of circulating IGF-binding proteins. Insulin-like growth factors 1 and 2 have a critical physiological role in the growth and development of many tissues, and are also implicated in various pathological conditions, particularly in multiple myeloma (MM).
2011
5
872
874
Moreau P; Cavallo F; Leleu X; Hulin C; Amiot M; Descamps G; Facon T; Boccadoro M; Mignard D; Harousseau JL.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/133271
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 49
social impact